Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
to the development and aggressiveness of CLL and other B malignancies. This project aims to describe the role of candidate TFs in the development and progression of B-cell malignancies with emphasis on CLL while also
-
innovative approaches to sequester chloride and prevent it from aggressively etching away at metal surfaces, aka pitting corrosion, known to destroy the mechanical integrity of engineered structures
-
, self injurious behavior, imminent aggression, elopement and fall risks. Develops, discusses and communicates a realistic, individualized plan of care for each patient, in collaboration with the patient
-
) Applications must be submitted online at http://www.jobs.mtu.edu/postings/ and contain the following: cover letter, curriculum vitae, and teaching philosophy statement. Applicants will be asked to provide
-
dependent educational benefits Life insurance coverage Employee discounts programs For detailed information on benefits and eligibility, please visit: http://uhr.rutgers.edu/benefits/benefits-overview
-
to infectious and contagious diseases. Subject to varying and unpredictable situations. Handles emergency or crisis situations. May be exposed to clients exhibiting assaultive or aggressive behaviors. Generally
-
contagious diseases. Subject to varying and unpredictable situations. Handles emergency or crisis situations. May be exposed to clients exhibiting assaultive or aggressive behaviors. Generally pleasant working
-
. Subject to varying and unpredictable situations. Handles emergency or crisis situations. May be exposed to clients exhibiting assaultive or aggressive behaviors. Generally pleasant working conditions in a
-
treatment for common cancers, while offering hope for many patients with difficult or aggressive cancers who have struggled to find treatment options elsewhere. Why work for the University? We have AMAZING
-
expand the reach of the CU Cancer Center. Our expertise across cancer types helps us provide world-class treatment for common cancers, while offering hope for many patients with difficult or aggressive